| Literature DB >> 29793427 |
Emily J Cameron1, Susan K Bowles2,3, Emily Gard Marshall4, Melissa K Andrew5.
Abstract
BACKGROUND: Falls and the resulting complications are common among frail older adults. We aimed to explore risk factors and potential prevention strategies for falls in elderly residents of Long-Term Care Facilities (LTCF).Entities:
Keywords: Falls; Frail elderly; Long-term care; Nursing homes; Polypharmacy; Potentially inappropriate medication; Primary health care
Mesh:
Substances:
Year: 2018 PMID: 29793427 PMCID: PMC5968500 DOI: 10.1186/s12875-018-0741-6
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Resident characteristics
| Resident Characteristics | |
| Age (years) | Median (IQR) |
| Median age of residents | 85 (77 – 90) |
| Sex | % (N) |
| % Female | 68.1 (269) |
| Martial Status | % (N) |
| Married | 16.7 (66) |
| Single | 11.9 (47) |
| Divorced | 8.6 (34) |
| Widowed | 38.5 (152) |
| Unknown | 24.3 (96) |
| Vision | % (N) |
| Impaired | 39.1 (108) |
| Frailty | % (N) |
| Mild | 7.6 (30) |
| Moderate | 27.1 (107) |
| Severe | 32.7 (129) |
| Very Severe | 4.1 (16) |
| Terminally ill | 0.8 (3) |
| Missing data | 27.8 (110) |
| Cognition | %(N) |
| Dementia | 64.1 (253) |
Fig. 1Total number of Falls Reported per Resident
Associations of individual variables with falls (univariate analyses)
| Factor | β value (95% CI) | |
|---|---|---|
| Male Gender | −0.69 (−1.20, −0.17) | 0.009 |
| Dementia | 0.85 (0.26, −1.43) | 0.005 |
| Increased Frailty | −0.16 (− 0.54- 0.21) | 0.39 |
| Benzodiazepines | −0.47 (− 0.96, 0.17) | 0.058 |
| SSRI | 0.43 (−0.58, 0.91) | 0.084 |
Medication class in relation to number of falls
| Medication | N of residents taking each med. | 0 ( | 1 ( | 2-4 ( | 5+ ( | |
|---|---|---|---|---|---|---|
| Typical antipsychotics | 30 | 9 (30%) | 9 (30%) | 8 (27%) | 4 (13.3%) | 0.4 |
| Atypical antipsychotics | 156 | 66 (42.3%) | 41 (26.3%) | 33 (21.2%) | 14 (9.0%) | 0.96 |
| SSRI/SNRI | 219 | 97 (44.3%) | 47 (21.5%) | 51 (23.3%) | 22 (10.0%) | 0.03 |
| Diuretic | 193 | 85 (44.0%) | 52 (26.9%) | 36 (18.7%) | 16 (8.3%) | 0.94 |
| Beta blocker | 186 | 82 (44.1%) | 48 (25.8%) | 36 (19.4%) | 17 (9.1%) | 0.95 |
| CCB | 104 | 41 (39.4%) | 29 (27.9%) | 23 (22.2%) | 8 (7.7%) | 0.81 |
| ARB | 54 | 27 (50%) | 11 (20.3%) | 12 (20.45) | 2 (3.7%) | 0.31 |
| Opioid | 211 | 92 (43.65) | 61 (28.9%) | 41 (19.4%) | 17 (8.1%) | 0.83 |
| Statin | 149 | 68 (45.6%) | 39 (26.2%) | 30 (20.1%) | 10 (6.7%) | 0.72 |
| Diabetic | 106 | 45 (42.5%) | 33 (31.1%) | 20 (18.95) | 7 (6.6%) | 0.62 |
| Bisphosphonate | 64 | 28 (43.8%) | 13 (20.3%) | 17 (26.6%) | 6 (9.4%) | 0.41 |
| Benzodiazepines | 164 | 74 (45.1%) | 53 (32.3%) | 26 (15.9%) | 10 (6.1%) | 0.05 |
CCB Calcium Chanel Blocker, ARB Angiotensin Receptor Blocker, SSRI/SNRI Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinepherine Reuptake Inhibitors
Frailty in relation to gender, benzodiazepine use and number of falls
| 1- mild frailty | 2 - moderate frailty | 3 - severe frailty | 4 – very severe frailty | 5 – terminally ill | ||
|---|---|---|---|---|---|---|
| Male Gender | 11 (12%) | 40 (43.4%) | 33 (35.9%) | 6 (6.5%) | 2 (2.2%) | 0.21 |
| Female Gender | 19 (10%) | 67 (34.9%) | 95 (49.5%) | 10 (5.2%) | 1 (0.5%) | 0.21 |
| Benzodiazepine Use | 13 (11.0%) | 42 (35.6%) | 59 (50%) | 2 (1.7%) | 2 (1.7%) | 0.11 |
| 0 Falls | 14 (12.4%) | 41 (36.3%) | 50 (44.3%) | 7 (6.2%) | 1 (0.9%) | 0.95 |
| 1 Fall | 6 (8.1%) | 27 (36.5%) | 36 (48.6%) | 4 (5.4%) | 1 (1.4%) | 0.95 |
| 2-4 Falls | 5 (7.1%) | 30 (42.9%) | 31 (44.3%) | 3 (4.3%) | 1 (1.4%) | 0.95 |
| 5+ Falls | 5 (18.5%) | 9 (33.3%) | 11 (40.7%) | 2 (7.4%) | 0 | 0.95 |
Fig. 2Individual variables in relation to falls risk. Shown are linear regression coefficients with 95% Confidence Interval from the fully adjusted multivariable regression model